default author photo

Thang Cong Tran

PATH

2201 Westlake Avenue, Suite 200

Seattle, WA 98121

United States

SCHOLARLY PAPERS

2

DOWNLOADS

105

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Safety and Immunogenicity of an Egg-Based Inactivated Newcastle Disease Virus Vaccine Expressing SARS-CoV-2 Spike: Interim Results of a Randomized, Placebo-Controlled, Phase 1/2 Trial in Vietnam

Number of pages: 28 Posted: 10 Feb 2022
National Institute of Hygiene and Epidemiology, National Institute of Hygiene and Epidemiology, affiliation not provided to SSRN, Hanoi Medical University, Hanoi Medical University, Hanoi Medical University, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Mahidol University, Center of Excellence for Biomedical and Public Health Informatics (BIOPHICS), University of Texas at Austin - Department of Molecular Biosciences, affiliation not provided to SSRN, QBI Coronavirus Research Group (QCRG), Mount Sinai School of Medicine - Department of Microbiology, Mount Sinai School of Medicine - Department of Microbiology, Mount Sinai School of Medicine - Department of Microbiology, Mount Sinai School of Medicine - Department of Microbiology, Mount Sinai School of Medicine - Department of Microbiology, affiliation not provided to SSRN, affiliation not provided to SSRN, Icahn School of Medicine at Mount Sinai - Department of Microbiology, affiliation not provided to SSRN, affiliation not provided to SSRN, PATH, PATH, PATH, PATH, PATH, PATH, PATH, PATH and PATH
Downloads 64 (933,592)

Abstract:

Loading...

SARS-CoV-2, COVID-19, Newcastle disease virus, Egg-based vaccine

2.

Safety and Immunogenicity of an Inactivated Recombinant Newcastle Disease Virus Vaccine Expressing Sars-Cov-2 Spike: A Randomised, Comparator-Controlled, Phase 2 Trial

Number of pages: 26 Posted: 30 May 2024
National Institute of Hygiene and Epidemiology, National Institute of Hygiene and Epidemiology, National Institute of Hygiene and Epidemiology, affiliation not provided to SSRN, PATH, La Jolla Institute for Allergy and Immunology (LIAI), affiliation not provided to SSRN, PATH, PATH, PATH, PATH, La Jolla Institute for Allergy and Immunology (LIAI), affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, La Jolla Institute for Allergy and Immunology (LIAI) - Division of Vaccine Discovery, PATH, Icahn School of Medicine at Mount Sinai - Department of Microbiology and La Jolla Institute for Allergy and Immunology (LIAI)
Downloads 41 (1,170,409)

Abstract:

Loading...

SARS-CoV-2, COVID-19, Newcastle disease virus, Egg-based vaccine, Phase II clinical trial